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Outer membrane vesicles (OMVs) from Gram-negative bacteria were first considered as artifacts and were
followed with disbelief and bad reputation. Later, their existence was accepted and they became characterized
as bacterial bombs, virulence bullets, and even decoys. Today, we know that OMVs also can be involved in
cellcell signaling/communication and be mediators of immune regulation and cause disease protection.
Furthermore, OMVs represent a distinct bacterial secretion pathway selecting and protecting their cargo, and
they can even be good Samaritans providing nutrients to the gut microbiota maintaining commensal
homeostasis beneficial to the host. The versatility in functions of these nanostructures is remarkable and
includes both defense and offense. The broad spectrum of usability does not stop with that, as it now seems
that OMVs can be used as vaccines and adjuvants or vehicles engineered for drug treatment of emerging and
new diseases not only caused by bacteria but also by virus. They may even represent new ways of selective
drug treatment.
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O
uter membrane vesicles (OMVs) are released
from Gram-negative bacterial cells, as well as
from Archaea, fungi, and parasites. The produc-
tion of OMVs was first reported more than 40 years ago (1)
but their full biological significance was first recognized
recently, particularly in Gram-negative bacteria. Membrane
vesicle (MV) production in Gram-positives was long over-
looked (2) but has now been demonstrated in Streptococcus
pneumoniae, Streptococcus mutans, Staphylococcus aureus,
and Bacillus subtilis (25). OMVs range in size from 20 to
300 nm in Gram-negative bacteria. MVs in Gram-positive
bacteria are somewhat smaller. Due to their small size they
have been characterized as nanovesicles (6, 7). The vesicle
membrane in Gram-negative bacteria is somewhat different
from that of the outer membrane (OM) although there
are great similarities (8). It is still unclear how OMVs are
generated in detail. They are formed when the OM bulges
and encapsulates periplasmic components (911) (Fig. 1)
which involve membrane remodeling (8).
The present review will deal mainly with OMVs from
Gram-negative bacteria where they can be derived from
both pathogenic and non-pathogenic species. OMVs used
to have a disreputable past, first being considered as
debris or artifacts (12). Today, we know that OMVs have
very diverse functions. They are involved in both defense
and offense. The field is quite extensive and only major
functions will be dealt with. Functions mentioned for
OMVs of the periodontopathogenic Porphyromonas gin-
givalis and Aggregatibacter actinomycetemcomitans are
listed in Table 1.
OMVs as communication tools
OMVs as secretion system
OMVs enable secretion of insoluble or hydrophobic
material such as lipids, membrane proteins, and signaling
molecules (13). They have a number of advantages over
simple secretion systems in bacteria because the cargo is
protected inside the lumen of the vesicle which can be
targeted to specific destinations through receptors (14).
In the case of gentamicin-containing OMVs, these OMVs
may help eradicate even intracellular pathogens not
reached by gentamicin in external body fluids (15).
Different toxins can be transported by OMVs in different
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bacteria. In A. actinomycetemcomitans, biologically active
cytolethal distending toxin (CDT) depended on vesicle
transport into HeLa cells and human gingival fibroblasts
(16). OMVs were internalized in these cells by fusion
with lipid rafts in the plasma membrane and the active
toxin unit, CdtB, was localized inside the nucleus of the
intoxicated cells. It has been suggested that OMVs, due to
their preponderance in biofilms, could be used to deliver
cell toxins which would affect only the intended target (7).
OMVs can also be internalized in host cells with the re-
sult that intracellular constituents can become degraded
leading to cellular malfunction (17).
Many organisms use OMVs to secrete virulence factors.
Examples are cytotoxin Cly from Escherichia coli and
Salmonella enterica serovar Typhi, the heat-labile entero-
toxin of enterotoxigenic E. coli and the vacuolating
cytotoxin VacA of Helicobacter pylori (reviewed by Ref.
18). Notably, bacteria actively regulate their OMV cargo
to manipulate the host-pathogen interplay.
Gentamicin has been shown to induce Pseudomonas
aeruginosa to generate OMVs containing this aminoglyco-
side (19). The OMVs were similar to natural ones except
that they contained small amounts of gentamicin. The
synergistic effect of antibiotic plus autolysin in gentamicin-
containing OMVs can suggest a novel strategy as how to
deal with hard-to-kill pathogens (19). OMVs can also
deliver enzymes and lipopolysaccharide (LPS) in high
concentration to the target as a package (11) excreting
membrane-perturbing substances from the cell. Dorvard
et al. (20) proposed that OMVs can function as a mecha-
nism of genetic exchange between cells because they
are efficient mediators of genetic transformation. Indeed
DNA in OMVs has been successfully transferred into
other bacterial cells, even between cells of different species
(2022). This may represent a so far little recognized DNA
delivery system for bacteria (20, 23, 24).
OMVs can contain b-lactamases which may protect
bacterial species against the stress of antibiotics (2528).
This could represent a new form of drug delivery (2931).
When bacterial cells are among non-competitors their
OMVs probably deliver ‘benign’ messages, whereas the
cargo may change when the cells are faced with stress,
competition, or prey (7). To be able to differentiate bet-
ween messages from a friend or foe OMVs would
probably need a barcode-like recognition system (7).
Effect on innate and adaptive immune system
Through delivery of enzymes, toxins, communication
signals, and antigens, OMVs can influence the innate and
adaptive immune systems (18). In bacterial OMVs, Toll-
like receptor ligands such as LPS and lipoproteins
stimulate maturation of and cytokine release by macro-
phages and dendritic cells (DCs). This may promote the
pathogenesis of infections. Furthermore, peptidoglycan-
containing OMVs upregulated nuclear factor-kappaB
(NF-kB) and nucleotide-binding oligomerization domain
(NOD)1-dependent responses in vitro (32, 33). This was
suggested as a new mechanism whereby Gram-negative
bacteria can deliver peptidoglycan to cytosolic NOD1
in host cells and thereby promote inflammation and
pathology.
Fig. 1. OMVs observed at the outer cell membrane in
P. gingivalis with transmission electron microscopy. A:
Membrane-blebbing OMVs in strain ATCC 33277T (type I
fimA strain). B: OMVs through the blebbing and pinching-
off of the outer membrane in strain TDC 60 (type II fimA
strain). Bars200 nm.
Table 1. Functions of OMVs from Porphyromonas gingivalis
and Aggregatibacter actinomycetemcomitans mentioned in
this review
P. gingivalis A. actinomycetemcomitans
Ref Ref
OMVs as
communication
tools
OMVs as a secretion
system
17 16
Effect on innate and
adoptive immunity
34
Ecological
determinants
42, 43, 45,
46, 47, 52,
53, 54
48, 51, 57
OMVs as offensive
weapons
Adhesion and
invasion
61, 62, 63,
64
Virulence bullets/
bacterial bombs
76, 77, 78,
81, 82, 83
74
Sepsis 93, 94
OMVs as possible
good Samaritans
Vaccines/adjuvants 97
Classification 99
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OMVs-containing antigens such as surface proteins and
LPS are probably potent stimulators of the adaptive
immune response and both B and T cell antigens have
been identified in OMVs (18). In A. actinomycetemco-
mitans, OMVs after internalization into human cells, acted
as a trigger of innate immunity by carrying NOD1 and
NOD2-active pathogen-associated molecular patterns
into host cells (34). It was suggested that OMV inter-
nalization can represent an important mechanism for
intracellular exposure of antigens for A. actinomycetemco-
mitans. Interestingly, because A. actinomycetemcomitans
triggers bone resorption mainly via NOD1, intracellular
delivery of NOD1 via OMVs may induce periodontal bone
loss (34).
Antigen decoys
OMVs may act as decoys in vivo meaning that they
redirect the antibody response making antibodies inef-
fective for clearance of intact organisms (18). Thus,
proteins and carbohydrates in OMVs may act as addi-
tional and significant antigen sources beyond those
provided by the organism. This was seen in Moraxella
that avoided direct interaction with host B cells by
redirecting the adaptive humoral immune response by
using superantigen-bearing OMVs as decoys resulting in
the production of antibodies ineffective for elimination of
intact organisms (35). Moraxella catarrhalis can actually
direct the humoral immune response away from itself.
In this bacterium, OMV secretion probably represents a
sophisticated mechanism to modify host immune re-
sponse avoiding direct contact between bacterium and
host (36). Microbes can also modulate the host response
to suit their lifestyle while staying inside the host, and
they can modify the microbial surface to avoid immune
detection. Also, OMVs can act as a decoy target for
phages (37, 38). In biofilms OMVs have been suggested
to serve as decoys for bacteria growing there (39). OMVs
can also alleviate stress caused by peptide antibiotics by
acting as decoys and transporting these molecules away
from the parent cells (38).
Cross-kingdom dialogs
OMVs can mediate intercellular exchange such as cell-cell
signaling. In the gut, a bacterial homolog of a eukaryotic
inositol phosphate signaling enzyme (InsP6 phosphatase
or MINPP) was found to mediate cross-kingdom dialog
(40). It was demonstrated that MINPP from Bacteroides
thetaiotaomicron (BtMinpp) was packaged inside OMVs
protecting the enzyme from degradation by external
bacterial proteases. Furthermore, BtMinpp-OMVs inter-
acted with intestinal epithelial cells to promote intracel-
lular Ca2 signaling. In other words, a bacterial enzyme
was used to mediate dialog between gut bacteria and the
human host. This is a good example of how the micro-
biota can serve human gastrointestinal physiology and
how commensal gut bacteria can use OMVs in a manner
that is beneficial to the host.
Intermicrobial communication
OMVs are known to exert important functions not only in
inter-kingdom communication but also in intercellular
and inter-species communication (18). Intermicrobe cross
talk is promoted by OMV release. Examples are P.
aeruginosa that releases quorum-sensing signaling mole-
cules pqs (Pseudomonas quinolone signal) and Haemophilus
influenzae that releases DNA in OMVs (transformasomes)
(18). They are effective mediators of communication even
at long distances (41).
Ecological determinants
OMVs, being able to specifically concentrate the release
of a large number of its virulence factors into the
environment (42) could probably regulate the ecology at
the site they are acting against promoting disease, for
example, early onset periodontitis.
OMVs can be involved in coaggregation of bacterial
cells (4347) and in adhesion of bacteria, for example, A.
actinomycetemcomitans to KB epithelial cells (subline of
the ubiquitous keratin-forming tumor cell line HeLa) (48).
OMVs from a biofilm-forming H. pylori strain stimulated
biofilm formation in another strain (49). OMVs of P.
gingivalis contained multiple complexes of adhesins which
caused cellular aggregation, autoaggregation, and coag-
gregation with a number of oral bacteria thereby enabling
formation of dental plaque and influencing its ecology (43,
45). In P. gingivalis, OMVs promoted adherence between
homologous cells and also mediated attachment between
non-aggregating bacterial species (43). Kamaguchi et al.
(45) found that OMVs from P. gingivalis have the ability to
aggregate with a wide range of Streptococcus species,
Fusobacterium nucleatum, Actinomyces naeslundii, and
Actinomyces viscosus. When P. gingivalis OMVs were
present, S. aureus also coaggregated with Streptococcus
species and the mycelial form of Candida albicans. It was
suggested that strains of S. aureus, even the methicillin
resistant S. aureus (MRSA) type, could adhere to sub-
gingival plaque with P. gingivalis present. It has also been
shown that P. gingivalis or its OMVs can increase at-
tachment and invasion of Tannerella forsythia to epithelial
cells (46). The mixed interaction of the two red complex
bacteria P. gingivalis and T. forsythia may increase period-
ontitis pathogenesis through OMV action. The HGP 17
domain was found to be responsible for P. gingivalis OMV-
mediated aggregation with Prevotella intermedia (47).
OMVs from A. actinomycetemcomitans promote da-
mage to the sulcular/periodontal epithelium by transport-
ing CDT and LPS to the subgingival area (50, 51). OMVs
can therefore act as a transport system to bring virulence
factors into host cells affecting the microbial ecology
of these cells. OMVs from P. gingivalis mediated coag-
gregation and piggybacking of Treponema denticola and
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Lachnoanaerobaculum saburreum (52). This may be a
mechanism that provides access of non-motile bacteria to
new niches where they might not otherwise be able to
penetrate. P. gingivalis OMVs also mediated coaggrega-
tion between Capnocytophaga ochracea and L. saburreum
(43). Besides, OMVs from P. gingivalis bound to and
aggregated A. viscosus and A. naeslundii cells (53). They
also attached to serum-coated hydroxyapaptite (54). In
the OMV-cell recognition, LPS has been suggested to
play a role (7).
OMVs can also facilitate transport of material between
bacteria to maintain the microbiota (36). They can transfer
antibiotic-resistance plasmids among Gram-negative
bacteria (20) and P. aeruginosa may deliver antibiotic-
resistance enzymes to other bacteria (55). Delivery of
murein hydrolase was demonstrated when P. aeruginosa
OMVs fused with E. coli and associated with S. aureus (19).
It has been suggested that murein hydrolases in OMVs can
be an effective way of bringing enzymes to the surfaces of
other cells. This could imply fusion of OMVs with foreign
membranes (56, 57). Vesicles from Shigella flexneri and
P. aeruginosa rapidly fused with the OM of other Gram-
negative bacteria (58). Fusion may cause incorporation
of vesicle components directly into the cytoplasmic
membrane or the cytoplasmic lumen of host cells.
Bacteroides OMVs may have a ‘social’ function since
oligosaccharides, monosaccharides, and amino acids
resulting from the activity of their containing hydrolytic
enzymes could be made available for other bacteria (59).
OMV-packed hydrolases from this bacterium could play
an important role in the microbial ecology of the gut (60).
Also, digestion of polysaccharides by hydrolases present
in OMVs could support the growth of bacteria that are
unable to degrade polysaccharides, thereby contributing
to the gut homeostasis. This could create balanced
ecological units within the gut microbiota (60).
b-lactamases in M. catarrhalis OMVs were found to
enhance survival of its own species and also promote
infection with co-inhabiting pathogens such as H. influ-
enzae and S. pneumoniae (25). This clearly demonstrated
the role of OMVS as an ecological determinant and
that can be used by bacteria to establish a colonization
niche (36).
OMVs as offensive weapons
Adhesion and invasion
P. gingivalis OMVs swiftly adhered to human gingival
epithelial cells in a fimbriae-dependent manner, and then
entered via a lipid rafts-dependent endocytic pathway
through the assembly of actin filaments (Fig. 2). The
OMVs were routed to early endosomes and thereafter
sorted to proteolytic lysosomes (17). Following cell entry,
P. gingivalis OMV-associated gingipains degraded cellular
functional molecules causing cellular impairment, which
included the cellular transferrin receptor and paxillin
(integrin-related signaling molecule)/focal adhesion kinase.
This caused depletion of intracellular transferrin and
inhibition of cellular migration (17).
It has been shown that microspheres coated with P.
gingivalis vesicles are adhesive and interact with both
bacteria and host cells (6163). They could even invade
host cells and cause cell death (62, 63). Recently, it was
demonstrated that minor components of long fimbriae
(FimC, D and E) but not FimA were involved in the inva-
sive activities of OMVs from P. gingivalis (64). Notably, P.
gingivalis strains that lacked or had a reduced FimA
expression exhibited a significant reduction in vesiculation
suggesting that production and pathogenicity of P.
gingivalis vesicles may depend to a large extent upon
expression of the fim locus. Invasion by OMVs could be a
new mechanism for P. gingivalis in periodontitis enabling
their gingipain content to degrade a range of intracellular
functional molecules, resulting in cellular impairment (65).
Bacterial defense
A significant task of OMVs is to remove agents that can
harm the cell-surface of the parent bacterium, for
example, antimicrobial peptides and T4 bacteriophages
(38). When bacterial cells were treated with lytic phage
Fig. 2. Entry of OMVs isolated from P. gingivalis ATCC 33277 into immortalized gingival epithelial cells. The cells were
incubated with OMVs (30 mg/ml) for 15 min, then further incubated for the indicated times. For fluorescence microscopy, the
cells were processed for staining for OMVs (green) and actin (Alexa Fluor 568-conjugated phalloidin red).
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OMV production increased the survival of the cells (38).
The number of OMVs released from bacteria seems to be
related to stress which may promote biofilm formation
and biofilm-specific antibiotic tolerance and resistance
(6668). As mentioned OMVs can probably deliver anti-
biotics in high concentrations to the target as a package
(11) and the biofilm mode of growth can protect them
against antimicrobial substances (68). OMVs also have a
role in antimicrobial peptide resistance (69). They protect
against host antibodies and proteases thereby increasing
the half-life of toxins packed inside (70, 71). Besides, they
can adsorb antibiotics and complement (72).
Virulence bullets/bacterial bombs
OMVs have been designated both as virulence bullets and
bacterial bombs. Because a distinction is not easy to
make these terms will be used together.
OMVs can be involved in cellcell inhibition and killing
among competing bacterial cells. Thus, they can carry
antimicrobials that selectively kill cells from other species
(15, 73). In A. actinomycetemcomitans OMVs, a leukotoxin
kills lymphocytic and monomyelocytic cell lineages which
should defend the periodontal pocket against infection.
OMVs from the highly leukotoxic strain JP2 were 5- to
10-fold more toxic than vesicles from the minimally toxic
strain 652 (74). The vesicles of JP2 were also 4- to 5-fold
more toxic than their OM preparations. Therefore, forma-
tion of OMVs in A. actinomycetemcomitans involved
enrichment of leukotoxin. OMVs of P. gingivalis contain
gingipains which remodel the normally symbiotic micro-
biota into a dysbiotic one by C5 convertase action (75).
Grenier and Be´langer (76) suggested that OMVs and LPSs
released by P. gingivalis could protect other bacteria from
complement action in the periodontal pocket thereby
favoring periodontal disease. P. gingivalis OMVs can also
induce formation of murine macrophage foam cells (77)
and are potent activators and aggregative factors for
murine platelets, although initial adherence may be
mediated by fimbriae (78).
Toxins and virulence factors in OMVs are often shipped
directly to host cells (11). Actually, OMVs can deliver their
toxins without environmental degradation, immune detec-
tion, or dilution of their cargo (56, 79). They can also
deliver their toxins and other virulence factors at high
concentrations to distant targets and mammalian cells
without close contact (for review, see 34). OMVs can
harbor large amounts of LPS which normally is a major
component of the outer leaflet of the OM. In P. aeruginosa
modulation of O-polysaccharide expression had an influ-
ence on the physical and compositional properties of
OMVs suggesting a role in the differential protein sorting
of different strains (10). Kadurugamuwa and Beveridge
(11) found that in this species natural OMVs were strongly
enriched in serotype specific antigen (B-band) in the O-
antigen portion of LPS. This was in contrast to the lipid
composition of the OM. Bacteria can even modify their
OMV cargo according to the environment implying that
the OMV components and cargo might be actively sorted
by the producing cell (14). In P. gingivalis, gingipains which
are major virulence factors were selectively sorted out as
OMV cargo whereas other abundant OM proteins, for
example, those involved in the nutrient uptake, were
excluded but remained in the OM (80). Accordingly,
OMV production was a result of a directed process where
specific events were involved in specific exclusion and/or
inclusion of protein sorting into the OM and OMVs (8).
Bacteria have different methods for recruiting cargo
into their OMVs (8). The O-antigen of LPS can have a
role in the selection of the protein cargo. In P. gingivalis,
which produces two classes of LPS with either neutral
(O-LPS) (81) or negatively charged (A-LPS) O-antigen
chains (82, 83), the cargo proteins may have a domain
that recognizes the long A-LPS molecules enriched in the
OMVs (80). Virulence factors of ecologic importance in
P. gingivalis are gingipains (RgpA/B and Kgp) which are
among the favored OMV cargo (42, 80). This implies
that P. gingivalis has the ability to selectively sort its
C-terminal domains proteins into OMVs.
In Gram-negative bacteria OMVs can be enriched in
toxins, quorum-sensing molecules, misfolded proteins, and
DNA (8). Proteins of the OMVs are sorted and also
glycans can be involved in the sorting. In A. actino-
mycetemcomitans a subpopulation of OMVs was found
with slight variation in the protein composition (34).
Actually, OMVs from A. actinomycetemcomitans could
deliver multiple proteins simultaneously including OmpA
and biologically active cytolethal toxin into HeLa cells and
gingival fibroblasts (16). Also in S. pneumoniae MVs, many
reported immunogenic protein antigens were found (2),
including toxin Ply which is its most widely studied
virulence factor. In cystic fibrosis, cystic fibrosis trans-
membrane conductance regulator (CTFR) is required for
mucociliary clearance. P. aeruginosa promotes degradation
of CTFR through the OMV-packed toxin Cif (CTFR
inhibitory factor) (8). Cif is brought to host cells after
OMV fusion with lipid rafts causing lysosomal degrada-
tion of CFTR (56).
OMVs from one bacterium can kill competing mi-
crobes in its vicinity (73). Killing was most efficient if the
target bacteria possessed peptidoglycan similar to the
OMV donor. If the peptidoglycan hydrolases were similar
to those of the target strain they were unable to cleave the
peptidoglycan layer (13). This may change if they fuse
with cells of a different strain. In that case they can
degrade the cell wall and kill the target cell (84). OMVs
from bacteria can also fuse with OM of other bacteria.
This may release vesicle-encapsulated autolysin to the
periplasm thereby causing lysis of the target organisms.
This predatory response may allow microcolonies to live
in a biofilm at the expense of neighboring cells (85, 86).
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Sepsis
Oral bacteria can be associated with systemic diseases
(87). Bacteria frequently disseminate through the blood,
particularly in periodontitis. OMVs are important sources
of inflammatory stimulants both locally and systemically
when entering the circulation (88). They induce a robust
systemic inflammatory response causing organ damage
and death in animals (89, 90). By initiating an inflamma-
tory response, they can induce sepsis in rats even when the
cells from which they were derived are absent (89). OMVs
also influence the inflammatory and coagulation cascade
and may thus contribute to the hypercoagulable response
in sepsis (91). Important in this context is their high
content of LPS which is a potent proinflammatory trigger.
OMVs from different bacteria can activate the immune
system in different ways (reviewed by 8) and stimulate the
production of proinflammatory mediators such as IL-8,
IL-6, IL-12, and TNF-a (92). P. gingivalis OMVs regulate
cells that participate in immune responses (93) and even
have a crucial role in mucosal immunogenicity (94).
OMVs as possible good Samaritans
Good Samaritans
OMVs can contribute to gut health via immunomodula-
tion of host responses or by providing nutrients to
members of the gut microbiota (8). Polysaccharide cap-
sular antigen (PSA) from Bacteroides fragilis reduced
inflammation in animals by inducing immune tolerance
(95). It seems that OMVs delivered this PSA directly to its
host through DCs (96). OMVs that are internalized by
DCs induce tolerogenic DCs that generate interleukin 10
(IL-10) which in turn drives the development of IL-10
producing regulatory T-cells (TREGS). Therefore, PSA
programs DCs to change into an anti-inflammatory profile
that can lead to T-cell-mediated tolerance and protection
from experimental disease such as colitis, inflammatory
bowel disease, and Crohn’s disease (96). It is likely that
delivery of PSA by OMVs contributes to the probiotic
properties of B. fragilis in the gut enabling communication
between the microbiota and the immune system during
host-bacterial mutualism (96). In this interplay PSA of B.
fragilis is an archetypical symbiosis factor. Accordingly,
OMVs can be important tools for modulators of the
microbiota in the gut and in this sense they act as good
Samaritans (12). Whether similar modification of the oral
microbiota occurs is not known. However, it is likely (by
extrapolation) that ‘good Samaritan’ activities might be
delivered by vesicles in the mouth that are similar to those
reported for the gut ecosystem. It is not clear what
maintains the balance between OMVs causing destructive
events intracellularly and those that induce abenefit. In the
case of B. fragilis, it should be kept in mind that this
bacterium belongs to the commensal microbiota of the gut
and therefore probably represents no threat to Gram-
negatives trying to induce a dysbiotic gut microbiota.
Vaccines/adjuvants
Application of OMVs as vaccine antigens after intranasal
immunization of BALB/c mice gave high levels of P.
gingivalis-specific IgA in nasal washes and saliva and in
serum IgG and IgA. This suggested a potential role of P.
gingivalis OMVs as non-replicating mucosal immunogens
for vaccines against periodontal disease. The range of
virulence factors enriched in P. gingivalis OMVs may
make them particularly suited for a periodontal disease
vaccine (97). Neisserial OMVs are considered a successful
vaccine immunogen against bacterial meningitis (98) such
as the commercially available vaccine against Neisseria
meningitidis serogroup B. It is thought that OMVs are
safer as antigens than whole bacterial cells and can
harbor a number of cell-surface markers such as LPS and
proteins to stimulate an immune response (31). OMVs
have also been manipulated to act as adjuvants while
displaying foreign epitopes of interest resulting in some
success for producing a single vaccine against both (14).
Classification
OMVs have proved useful for classification of members
of the Actinobacillus-Haemophilus-Pasteurella group (99)
where several belong to the oral ecosystem.
Concluding remarks
OMVs have a number of functions as described in the
current review: virulence bullets, bacterial bombs, decoys,
vehicles for cellcell signaling, mediators of immune
regulation and disease protection, unique secretion sys-
tems, good Samaritans, and so on. It is amazing how these
small vesicles can serve functions that are good to
themselves and their parent bacteria and even to the
host. However, they have also clear detrimental effects
towards other bacteria and the host. There is no question;
these structures are both offensive weapons and good
Samaritans. Their diversity in function is remarkable.
We should probably try to modify them for the benefit of
the host, for example, as therapeutics against disease.
A specific field of interest is new and emerging bacterial
and virus infections where engineered OMVs containing
proteins might be used as decoys and vaccines.
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